American Association for Cancer Research: Outcomes After Stem Cell Transplant in Elderly Patients With Acute Myeloid Leukemia Have Improved Since 2000
March 23, 2024
March 23, 2024
PHILADELPHIA, Pennsylvania, March 23 (TNSres) -- The American Association for Cancer Research issued the following news release:
Among patients over 65 who received an allogeneic hematopoietic stem cell transplant (allo-HCT) for the treatment of acute myeloid leukemia (AML) between 2000 and 2021, leukemia-free and overall survival improved significantly over time, according to results from a study published in Clinical Cancer Research, a journal of the American Association for Cance . . .
Among patients over 65 who received an allogeneic hematopoietic stem cell transplant (allo-HCT) for the treatment of acute myeloid leukemia (AML) between 2000 and 2021, leukemia-free and overall survival improved significantly over time, according to results from a study published in Clinical Cancer Research, a journal of the American Association for Cance . . .